comparemela.com

Latest Breaking News On - Centessa pharmaceuticals plc - Page 1 : comparemela.com

Centessa Pharmaceuticals Announces $100 Million Proposed

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that.

City ofUnited kingdomUnited statesNew yorkKristenk sheppardExchange commissionLeerink partnersProspectus departmentSyndicate departmentGoldman sachs coGoldman sachsCentessa pharmaceuticalsAmerican depositary sharesGuggenheim securitiesAnnual reportQuarterly reports

Centessa Pharmaceuticals to Present Preclinical Data for

Oral presentation to include preclinical profile for ORX750, Centessa’s first orexin agonist development candidate for the treatment of narcolepsy and.

City ofUnited kingdomUnited statesRio de janeiroEstado do rioDavid graingerKristenk sheppardKarl gibsonSaurabh sahaEmiliangelo rattiMario alberto accardiGregoryr ottDeborahs hartmanThomass kilduffTod steinfeldCentessa pharmaceuticals

Centessa Pharmaceuticals Receives Fast Track Designation

BOSTON and LONDON, May 22, 2023 (GLOBE NEWSWIRE) Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to.

United statesCity ofUnited kingdomKristenk sheppardExchange commissionCentessa pharmaceuticalsDrug administrationFast trackSaurabh sahaChief executive officerAccelerated approvalPriority reviewRolling reviewAnnual reportQuarterly reportsNasdaq cnta

Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022

United statesCity ofUnited kingdomKristenk sheppardCentessa predecessor groupUpcoming program milestonesAmerican society of hematologyLockbody technology platformEuropean association for haemophiliaCentessa pharmaceuticalsExchange commissionDrug administrationResearch development expensesCentessa pharmaceuticals reports recent business progressFinancial resultsFourth quarter

Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

United statesCity ofUnited kingdomNew yorkKristenk sheppardCentessa pharmaceuticalsUpcoming investorGuggenheim genomic medicinesRare diseaseVenrock boston biotechInvestegate announcementsInvestegate company announcementsCentessa pharmaceuticals plcLobenewswire and globenewswire

vimarsana © 2020. All Rights Reserved.